Our CEO in Conversation
Chief Executive Officer Dr. Wolfgang Wienand about Siegfried’s journey in 2022 and its priorities in the year to come.
CEO Wolfgang Wienand in the Pharma Network Magazine
We invest in our Global Network to support our Customers' Growth Ambitions
Media Release from the August 24, 2022
Siegfried begins construction of new large-scale production plant in Minden (DE)
Publication of Siegfried's Half Year Results 2022
With strong momentum through turbulent times: Siegfried significantly increases sales and profits in the first half of 2022 despite challenging environment
Come and find out more about a company with a strong tradition of innovation where you really can “expect more”.
Come and find out more about a company with a strong tradition of innovation where you really can “expect more”.
Explore more about how our broad range of customer development services, drug substance & drug product manufacturing and packaging capabilities together with our existing product portfolio may help you achieve greater value.